BRISBANE, Calif. and EDEN PRAIRIE, Minn., April 05, 2023 (GLOBE NEWSWIRE) -- CareDx, Inc. (CDNA) and Miromatrix Medical Inc. (MIRO) -- today announced an exclusive partnership aimed at advancing the ...
United Therapeutics’ bioengineered external liver assist system developed to treat patients with acute forms of chronic liver ...
Intermountain Medical Center participated in a trial of the first bioengineered external liver, designed to help acute liver failure patients or are not eligible for or are waiting for a transplant a ...
A phase 1 study of miroliverELAP for the treatment of acute liver failure is currently underway;1 first patient in the study underwent the procedure at Intermountain Medical Center in Murray, Utah ...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., January 26, 2026--United Therapeutics Corporation (Nasdaq: UTHR) today announced positive results from its phase 1 study of miroliverELAP®, an ...
(RTTNews) - Trestle Biotherapeutics, Inc. has partnered with Humacyte, Inc. (HUMA) to explore synergies in bioengineering vascularized organs for transplantation. Trestle Bio, a preclinical-stage ...
BROOKLYN, N.Y., April 2, 2025 /PRNewswire/ -- Xylyx Bio, Inc., a regenerative medicine company, announced that it has received $1,000,000 from the Richard M. Bartlett Jr. Memorial Foundation and ...
SAN DIEGO--(BUSINESS WIRE)--Trestle Biotherapeutics, Inc., today announced a research collaboration with Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing ...
Bioengineered organs are no longer just structural substitutes. A new review published in Trends in Biotechnology introduces a groundbreaking concept: biohybrid-engineered tissue (BHET) ...
United Therapeutics has reported positive phase 1 results for miroliverELAP, an external bioengineered liver assist device from its Miromatrix subsidiary, showing survival during treatment and no ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results